Insights

Innovative Platform Hyasynth Bio utilizes a cutting-edge microbial engineering platform that accelerates the production of natural molecules and derivatives, presenting opportunities for partnerships in microbial biotech, synthetic biology, and rapid drug development services.

Focused Investment With recent investments from Organigram and others totaling over CAD 4.45 million, the company demonstrates strong backing in cannabinoid research, suggesting potential for collaborations in cannabinoid manufacturing, product development, and specialized biotech solutions.

Market Positioning As a small biotech firm with a focus on cost-effective natural molecule synthesis, Hyasynth offers niche expertise that can be valuable to pharmaceutical companies seeking scalable, sustainable supply chains and innovative drug development alternatives.

Emerging Cannabis Focus Given recent investments in cannabinoid technologies, there is a clear opportunity to explore partnerships centered on novel minor cannabinoids, personalized medicine, and expanding applications within the growing legal cannabis market.

Technology Integration Hyasynth's blend of traditional and modern biology, combined with computational analysis, enables potential collaborations in bioinformatics, data-driven biotech, and automation solutions to enhance research efficiency and product development pipelines.

Similar companies to Hyasynth Bio

Hyasynth Bio Tech Stack

Hyasynth Bio uses 8 technology products and services including Open Graph, RSS, Google Workspace, and more. Explore Hyasynth Bio's tech stack below.

  • Open Graph
    Content Management System
  • RSS
    Content Management System
  • Google Workspace
    Email
  • Envoy
    Load Balancers
  • Branch
    Marketing Automation
  • Node.js
    Programming Languages
  • Google
    Search Engines
  • Apache
    Web Servers

Hyasynth Bio's Email Address Formats

Hyasynth Bio uses at least 1 format(s):
Hyasynth Bio Email FormatsExamplePercentage
First@hyasynthbio.comJohn@hyasynthbio.com
35%
First.Last@hyasynthbio.comJohn.Doe@hyasynthbio.com
15%
First@hyasynthbio.comJohn@hyasynthbio.com
35%
First.Last@hyasynthbio.comJohn.Doe@hyasynthbio.com
15%

Frequently Asked Questions

What is Hyasynth Bio's official website and social media links?

Minus sign iconPlus sign icon
Hyasynth Bio's official website is hyasynthbio.com and has social profiles on LinkedInCrunchbase.

What is Hyasynth Bio's SIC code NAICS code?

Minus sign iconPlus sign icon
Hyasynth Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Hyasynth Bio have currently?

Minus sign iconPlus sign icon
As of February 2026, Hyasynth Bio has approximately 5 employees across 2 continents, including North AmericaOceania. Key team members include Ceo, Co-Founder: K. C.Head Of People Operations: Z. W.Advisor To The Board: L. N.. Explore Hyasynth Bio's employee directory with LeadIQ.

What industry does Hyasynth Bio belong to?

Minus sign iconPlus sign icon
Hyasynth Bio operates in the Biotechnology Research industry.

What technology does Hyasynth Bio use?

Minus sign iconPlus sign icon
Hyasynth Bio's tech stack includes Open GraphRSSGoogle WorkspaceEnvoyBranchNode.jsGoogleApache.

What is Hyasynth Bio's email format?

Minus sign iconPlus sign icon
Hyasynth Bio's email format typically follows the pattern of First@hyasynthbio.com. Find more Hyasynth Bio email formats with LeadIQ.

How much funding has Hyasynth Bio raised to date?

Minus sign iconPlus sign icon
As of February 2026, Hyasynth Bio has raised $1.9M in funding. The last funding round occurred on Dec 22, 2021 for $1.9M.

When was Hyasynth Bio founded?

Minus sign iconPlus sign icon
Hyasynth Bio was founded in 2014.

Hyasynth Bio

Biotechnology Research2-10 Employees

Biology for people.

Natural molecules or derivatives make up more than half of the current drugs on the market with applications to nearly every disease known to humans. Salicylic acid, morphine, cannabinoids and insulin are a few examples. Our specialty is in producing these, and new targets, using a fast and scalable platform based on engineered microbes.

We use the technologies from traditional and modern biology combined with computational analysis to develop our organisms at the fastest possible speed. This makes our platform faster and cheaper than chemical synthesis or extraction from the natural source.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
2-10

Section iconFunding & Financials

  • $1.9M

    Hyasynth Bio has raised a total of $1.9M of funding over 11 rounds. Their latest funding round was raised on Dec 22, 2021 in the amount of $1.9M.

  • $1M

    Hyasynth Bio's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1.9M

    Hyasynth Bio has raised a total of $1.9M of funding over 11 rounds. Their latest funding round was raised on Dec 22, 2021 in the amount of $1.9M.

  • $1M

    Hyasynth Bio's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.